Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RVMD
Stock Latest News
The Fly
Revolution Medicines price target raised to $210 from $179 at Truist
2d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $235 from $183 at Needham
3d ago
RVMD
Premium
The Fly
Revolution Medicines begins treating patients in RASolute 305 trial
9d ago
RVMD
Premium
Company Announcements
Revolution Medicines Announces R&D Leadership Transition and Governance Votes
10d ago
8K
RVMD
Premium
Ratings
Revolution Medicines Earns Buy Rating on Strong PDAC Execution, First-Mover Advantage, and Daraxonrasib-Driven Growth Potential
23d ago
RVMD
Premium
Ratings
Revolution Medicines: RAS Combination Data and Phase III Plans Reinforce Pipeline Upside; Buy Rating and $175 Price Target Reiterated
23d ago
RVMD
Premium
The Fly
Tango Therapeutics price target raised to $69 from $55 at Leerink
24d ago
RVMD
TNGX
Premium
The Fly
RBC Capital says Tango-Revolution data strengthens daraxonrasib’s PDAC position
24d ago
RVMD
TNGX
Premium
The Fly
Tango Therapeutics announces data from study of vopimetostat, daraxonrasib
24d ago
RVMD
TNGX
Premium
Ratings
Analyst Reiterates Buy on Revolution Medicines Amid Strong ASCO Feedback and Optimism for RAS-Targeted Solid Tumor Portfolio
30d ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $182 from $165 at RBC Capital
30d ago
RVMD
Premium
The Fly
Wedbush reiterates Outperform on Revolution Medicines after ASCO data
1M ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $195 from $169 at H.C. Wainwright
1M ago
RVMD
Premium
The Fly
Revolution Medicines price target raised to $195 from $165 at Oppenheimer
1M ago
RVMD
Premium
Ratings
Ami Fadia Reiterates Buy on Strong Daraxonrasib Data, Maintains $183 Price Target
1M ago
RVMD
Premium
Ratings
Charles Zhu Reiterates Buy on RVMD, Maintains $263 Price Target on Strong Darax Data and Regulatory Progress
1M ago
RVMD
Premium
Ratings
Michael Yee Reiterates Buy Rating and Raises Price Target to $175 on Strong Pivotal Data and Launch Prospects for Daraxonrasib in Pancreatic Cancer
1M ago
RVMD
Premium
The Fly
Revolution Medicines announces results from Phase 3 RASolute 302 trial
1M ago
RVMD
Premium
The Fly
Bernstein starts Revolution Medicines at Market Perform, says upside baked in
1M ago
RVMD
Premium
The Fly
Revolution Medicines initiated with a Market Perform at Bernstein
1M ago
RVMD
Premium
The Fly
Revolution Medicines assumed with a Buy at Truist
2M ago
RVMD
Premium
Company Announcements
Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Raising Long-Term Upside Potential
2M ago
RVMD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
